Effects of lacidipine and nifedipine on lower limb veins in nonphlebopathic patients

J Cardiovasc Pharmacol. 1994:23 Suppl 5:S111-2. doi: 10.1097/00005344-199423005-00025.

Abstract

The aim of this study was to evaluate the effect of lacidipine and nifedipine on lower limb veins. Forty hypertensive patients, aged 30-50 years, with no deep venous thrombosis, venous insufficiency, or hypothyroidism underwent double-blind treatment with placebo (1 week), lacidipine 4 mg once daily (1 week), and slow-release nifedipine 20 mg twice daily (1 week) in randomized sequence. Echo-color Doppler examination of superficial, deep, communicating, and perforating veins of the legs was performed. The results showed venous insufficiency and hypertension after 1-week administration of lacidipine (5 and 15%, respectively) and nifedipine (10 and 25%, respectively) and only two cases (5%) of venous hypertension during placebo administration. Lower limb edema was observed in two patients (5%) during treatment with nifedipine slow-release (SR). The hemodynamic effects of lacidipine and nifedipine were reversible but may contribute to the mechanism of lower limb edema.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Calcium Channel Blockers / adverse effects*
  • Calcium Channel Blockers / therapeutic use
  • Delayed-Action Preparations
  • Dihydropyridines / adverse effects*
  • Dihydropyridines / therapeutic use
  • Double-Blind Method
  • Female
  • Hemodynamics / drug effects
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy
  • Leg / blood supply*
  • Leg / diagnostic imaging
  • Male
  • Middle Aged
  • Nifedipine / adverse effects*
  • Nifedipine / therapeutic use
  • Regional Blood Flow / drug effects
  • Ultrasonography, Doppler, Color
  • Veins / drug effects

Substances

  • Calcium Channel Blockers
  • Delayed-Action Preparations
  • Dihydropyridines
  • lacidipine
  • Nifedipine